Market Tracker

04/17 6:05pm ET

Celgene Corp (NASDAQ:CELG)

141.51
Data as of Apr 17
 -0.35 / -0.25%
Today’s Change
110.53
Today|||52-Week Range
174.66
-16.25%
Year-to-Date

Today’s Trading

Previous close141.86
Today’s open141.98
Day’s range140.29 - 144.07
Volume2,974,766
Average volume (3 months)3,905,583
Market cap$56.8B
Dividend yield--
Data as of 3:59pm ET, 04/17/2014

Growth & Valuation

Earnings growth (last year)+2.12%
Earnings growth (this year)+21.88%
Earnings growth (next 5 years)+25.35%
Revenue growth (last year)+19.49%
P/E ratio42.0
Price/Sales10.78
Price/Book10.26

Competitors

 Today’s
change
Today’s
% change
ABTAbbott Laboratories+0.55+1.43%
LLYEli Lilly and Co+0.47+0.78%
VRXValeant Pharmaceutic...+0.60+0.49%
ABBVAbbVie Inc+0.43+0.89%
Data as of 4:00pm ET, 04/17/2014

Financials

Next reporting dateApril 24, 2014
EPS forecast (this quarter)$1.65
Annual revenue (last year)$6.5B
Annual profit (last year)$1.4B
Net profit margin22.36%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Robert J. Hugin
Chief Operating Officer &
Executive Vice President
Perry A. Karsen
Corporate headquarters
Summit, New Jersey

Forecasts